Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Jobs
 

EquipNet Auction: Sell your surplus on our global marketplace: No cost to list equipment!

Check Out Our Newest Cartoon: "Milestones in Diabetes"

North American Biotech Roadshow Featuring Grad Students, Post-Docs & Start-Up “Do’s & Don’ts”


Washington Life Science Industry Directory

Women In Bio - Seattle

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2022 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Blaze Bioscience, Inc.


Blaze Bioscience, Inc.
530 Fairview Ave. N. Suite 1000
Seattle, WA 98109
Blaze Bioscience, Inc.
 
Phone: (206) 535-8144
Fax: (206) 257-5924
Year Established:  2010
Employees: 7
Main Contact: Mila Lobanova, MBA, VP, Finance & Operations
 
Other Contacts:  Laura Ishak, VP, Clinical Operations
Heather Franklin, President & CEO
Julie Novak, VP, Research
Claudia Jochheim, Ph.D., VP, Process Development and Manufacturing
Dennis Miller, Ph.D., D.A.B.T., Senior VP, Development
 
Company Description
Blaze Bioscience is a privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. Tumor Paint provides real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.